Website
N/ATelephone
N/A
Address
Description
BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. It also associated lipids, biomarker blood test that is used for prevention, screening and monitoring. The company was founded by Jayne Shaw and Ron Philips in 2010 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.08 - 0.21
Trade Value (12mth)
AU$10,029.00
1 week
-20.69%
1 month
-8%
YTD
18.56%
1 year
64.29%
All time high
0.28
EPS 3 yr Growth
650.000%
EBITDA Margin
N/A
Operating Cashflow
-$6m
Free Cash Flow Return
-76.80%
ROIC
-64.30%
Interest Coverage
-485.40
Quick Ratio
2.70
Shares on Issue (Fully Dilluted)
231m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
25 July 24 |
Directors Change of Interest Notice X 3
×
Directors Change of Interest Notice X 3 |
23 July 24 |
Application for quotation of securities - BDX
×
Application for quotation of securities - BDX |
23 July 24 |
Cleansing Notice
×
Cleansing Notice |
15 July 24 |
Results of Meeting
×
Results of Meeting |
11 July 24 |
BCAL to Present at Bioshares Biotech Summit - Presentation
×
BCAL to Present at Bioshares Biotech Summit - Presentation |
21 June 24 |
Change in substantial holding
×
Change in substantial holding |
17 June 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
13 June 24 |
Notice of General Meeting/Proxy Form
×
Notice of General Meeting/Proxy Form |
13 June 24 |
Letter to Shareholders re General Meeting 15 July 2024
×
Letter to Shareholders re General Meeting 15 July 2024 |
11 June 24 |
Application for quotation of securities - BDX
×
Application for quotation of securities - BDX |
11 June 24 |
Cleansing Notice
×
Cleansing Notice |
03 June 24 |
BCAL Receives Firm Commitments to Raise $10.5 Million
×
BCAL Receives Firm Commitments to Raise $10.5 Million |
03 June 24 |
Proposed issue of securities - BDX
×
Proposed issue of securities - BDX |
03 June 24 |
Proposed issue of securities - BDX
×
Proposed issue of securities - BDX |
03 June 24 |
Reinstatement to Quotation
×
Reinstatement to Quotation |
31 May 24 |
Suspension from Quotation
×
Suspension from Quotation |
30 May 24 |
Response to ASX Price Query
×
Response to ASX Price Query |
29 May 24 |
Pause in Trading
×
Pause in Trading |
29 May 24 |
Trading Halt
×
Trading Halt |
02 May 24 |
Company Presentation - Investor Insights
×
Company Presentation - Investor Insights |
01 May 24 |
Change in substantial holding
×
Change in substantial holding |
26 April 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
03 April 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
03 April 24 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
02 April 24 |
Trademark Registrations Received Ahead of Commercial Launch
×
Trademark Registrations Received Ahead of Commercial Launch |
27 March 24 |
Change in substantial holding
×
Change in substantial holding |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.